Vertex Pharmaceuticals (VRTX) total assets

Total assets · fiscal 2025
$25.64B

Vertex Pharmaceuticals (VRTX) had total assets of $25.64B at the end of fiscal 2025 (December 31, 2025). That is 13.8% higher than the $22.53B of fiscal 2024. Figures as of 18 Nov 2026, 03:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$25.64B
Change on fiscal 2024
+13.8%
Growth, 5 years
+16.9% a year
Growth, 10 years
+26.2% a year
Highest on record
$25.64Bfiscal 2025
Lowest on record
$1.73Bfiscal 2010
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vertex Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 16.9% a year; over ten years the rate was 26.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $25.64B in fiscal 2025 and the lowest $1.73B in fiscal 2010.

History · 17 fiscal years

Total assets by fiscal year

Vertex Pharmaceuticals total assets, year by year

Vertex Pharmaceuticals (VRTX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$25.64B 13.8% up
2024$22.53B 0.9% down
2023$22.73B 25.2% up
2022$18.15B 35.1% up
2021$13.43B 14.3% up
2020$11.75B 41.3% up
2019$8.32B 33.2% up
2018$6.25B 76.1% up
2017$3.55B 22.4% up
2016$2.90B 15.9% up
2015$2.50B 7.0% up
2014$2.33B 0.7% up
2013$2.32B 16.0% down
2012$2.76B 25.2% up
2011$2.20B 27.8% up
2010$1.73B 11.8% down
2009$1.96B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Vertex Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Pfizer PFE$208.16B2025
Danaher DHR$83.46B2025
Intuitive Surgical ISRG$20.46B2025
Vertex Pharmaceuticals VRTX$25.64B2025
Medtronic MDT$93.03B2026
Bristol-Myers Squibb BMY$90.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals total assets: questions and answers

How large are Vertex Pharmaceuticals's total assets?

Vertex Pharmaceuticals (VRTX) had total assets of $25.64B at the end of fiscal 2025 (December 31, 2025). That is 13.8% higher than the $22.53B of fiscal 2024.

What is the growth rate of Vertex Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 16.9% a year; over ten years the rate was 26.2% a year.

What are the highest and lowest total assets figures on record for Vertex Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $25.64B in fiscal 2025 and the lowest $1.73B in fiscal 2010.

How is Vertex Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.